Because signalling pathways, promoting cellular damage and destruction are similar in both senescent and cancer cells, the development of the new inhibitors to target specific Hsp90 isoforms could be a promising direction in both the extension of healthy ageing and as an anti-cancer therapy [84]. The gene discussed is HSP90AA1; the disease is cancer.